Randy Pardell
Psychiatry · Poughkeepsie, NYNPI 1578516969
Payments from drug & device makers
Across 220 payments — averaging $24.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$320
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$202
- Otsuka America Pharmaceutical, Inc.$180
- Lundbeck LLC$180
- plus $1K from 18 others
What the payments were for
- Travel & lodging$1,21123%
- Food & beverage$4,01075%
- Education$912%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 49 | $2,074 |
| AbbVie(2 entities) | 72 | $1,125 |
| Teva Pharmaceuticals USA, Inc. | 14 | $320 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $202 |
| Otsuka America Pharmaceutical, Inc. | 8 | $180 |
| Lundbeck LLC | 9 | $180 |
| Corium, LLC | 9 | $168 |
| Neuronetics, Inc. | 2 | $140 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $131 |
| Alkermes, Inc. | 4 | $107 |
| E.r. Squibb & Sons, L.L.C. | 5 | $96 |
| Axsome Therapeutics, Inc. | 4 | $90 |
| Neurocrine Biosciences, Inc. | 4 | $82 |
| Vanda Pharmaceuticals Inc. | 4 | $80 |
| Avanir Pharmaceuticals, Inc. | 4 | $76 |
| Jazz Pharmaceuticals Inc. | 3 | $61 |
| Ironshore Pharmaceuticals Inc. | 3 | $50 |
| Bausch Health US, LLC | 2 | $37 |
| Eisai Inc. | 1 | $23 |
| Vertical Pharmaceuticals, LLC | 1 | $23 |
| Shire North American Group Inc | 1 | $21 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$1,274
- NEUROSTAR TMS THERAPY$127
How this compares
$5,312 in reported general payments places this provider in the 90th percentile of 3,713 psychiatry providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 12 | $31,879 |
| RexultiBrexpiprazole | 14 | $22,146 |
| VyvanseLisdexamfetamine Dimesylate | 11 | $5,528 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 102 | $4,266 |
| Lisdexamfetamine Dimesylate | 19 | $4,095 |
| Duloxetine Hcl | 84 | $3,603 |
| Mirtazapine | 110 | $3,197 |
| Eletriptan HbrEletriptan Hydrobromide | 12 | $2,185 |
| Alprazolam XrAlprazolam | 14 | $1,971 |
| Bupropion XlBupropion Hcl | 57 | $1,909 |
| Vilazodone Hcl | 21 | $1,831 |
| Methylphenidate ErMethylphenidate Hcl | 23 | $1,817 |
| Olanzapine | 28 | $1,725 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 24 | $1,711 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 47 | $1,627 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $180 | $54,02526 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Vyvanse | $131 | $5,52811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,713 psychiatry providers in New York.
Other psychiatry in Poughkeepsie
- Kishor ZinzuvadiaPoughkeepsie$488K
- Elyssa BarronWhite Plains$12.8M
- Mark DibuonoStaten Island$11.9M
- Ronald BrennerHempstead$11.5M
- Anton PorsteinssonRochester$7.6M
- Michael LiebowitzNew York$7.1M
- Leslie CitromePomona$5.7M
- John KaneGlen Oaks$4M
- Inna Yuryev-GolgerBrooklyn$3M
- Subhdeep VirkBuffalo$3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.